Inherited arrhythmia syndromes (CPVT, short QT, early repolarisation)
Gene changes in the heart's ion channels can cause sudden fatal rhythms in hearts that look normal, often in children and young adults.
What it is
Inherited disorders of cardiac ion channels or calcium handling that cause ventricular arrhythmias and sudden death in a structurally normal heart. This page covers catecholaminergic polymorphic VT (CPVT), short QT syndrome and early repolarisation syndrome; long QT and Brugada syndromes have their own pages.
Who gets it
CPVT affects about 1 in 10,000 people, equally in both sexes, and usually presents before age 10; it causes an estimated 10 to 15% of sudden cardiac deaths in the young. Short QT syndrome is extremely rare. The early repolarisation pattern is common (about 9% of adults, more in young men, athletes and Black people), but the syndrome explains only about 2 to 3% of survived sudden cardiac deaths.
Causes
- CPVT: gain-of-function variants in the cardiac ryanodine receptor gene RYR2 (autosomal dominant, about half or more of cases, many new); CASQ2 (autosomal recessive, up to 5%); rarely CALM1–3 and TECRL
- Short QT: gain of function in repolarising potassium channels (KCNH2, KCNQ1, KCNJ2) or loss of inward sodium or calcium current; mostly autosomal dominant
- Early repolarisation syndrome: variants that increase outward potassium current or reduce inward sodium or calcium current; a specific gene is rarely found
- Acquired causes of J-point elevation to exclude: hypothermia or hyperthermia, hypocalcaemia, hyperkalaemia and ischaemia
Risk factors
- Family history of unexplained sudden death at a young age
- First-degree relative with a known causative variant
- Previous cardiac arrest or arrhythmic syncope
- Male sex (higher penetrance in short QT; early repolarisation pattern)
- Early repolarisation with high-risk features: J waves over 2 mm, changing J points, or a horizontal or descending ST segment
Pathophysiology
In CPVT, adrenaline makes a leaky ryanodine receptor release extra calcium from the sarcoplasmic reticulum; the calcium overload causes delayed afterdepolarisations that fire extra beats, building up to bidirectional or polymorphic VT and then VF. In short QT, overactive repolarising currents shorten the action potential, most in the epicardium, creating dispersion of repolarisation across the wall and a substrate for AF and VF; it is the mirror image of long QT. In early repolarisation, an exaggerated voltage gradient across the ventricular wall at the start of the plateau appears as J waves; Brugada syndrome belongs to the same J-wave family but shows in the right precordial leads.
Classification
- CPVT1 (RYR2, dominant) and CPVT2 (CASQ2, recessive)
- Short QT syndrome types by gene (KCNH2, KCNQ1, KCNJ2 and others)
- Early repolarisation pattern (an ECG finding) versus early repolarisation syndrome (the pattern plus VF, aborted sudden death or arrhythmic syncope)
- Related channelopathies with their own pages: long QT syndrome and Brugada syndrome
Symptoms and signs
- Often none until the first event; found on family screening or an incidental ECG
- Fainting or palpitations during exercise or emotional stress (CPVT)
- Sudden collapse or cardiac arrest
- Palpitations from atrial fibrillation at a young age (short QT)
- Seizure-like episodes that are really arrhythmic syncope
Diagnosis
- Clinical
- Suspect a channelopathy after unexplained syncope or cardiac arrest, or a family history of either, when the heart is structurally normal. Fainting with jerking during exercise needs a cardiac work-up before an epilepsy label.
- Tests
- CPVT: the resting ECG is normal; an exercise test that provokes increasing ventricular ectopy and bidirectional or polymorphic VT confirms it, and genetic testing finds a variant in about 60%. Short QT: a markedly short QTc together with history, family history or genotype; genetic yield about 20 to 30%. Early repolarisation: J-point elevation of at least 1 mm in two contiguous inferior or lateral leads plus the clinical history. Ambulatory rhythm monitoring; ECG, and exercise testing for CPVT, in first-degree relatives.
- Imaging
- Echocardiography and cardiac MRI to exclude structural disease, such as a cardiomyopathy, which would change the diagnosis.
Differential diagnosis
- Long QT syndrome and Brugada syndrome
- Arrhythmogenic or hypertrophic cardiomyopathy
- Epilepsy and reflex syncope
- Benign early repolarisation in athletes
- Electrolyte disorders and hypothermia
Young person, normal heart, sudden collapse: which channelopathy?
| Syndrome | Typical trigger | Resting ECG | Key test | Main treatment |
|---|---|---|---|---|
| CPVT | Exercise or emotion (adrenaline) | Normal | Exercise test: bidirectional or polymorphic VT | Non-selective beta-blocker, add flecainide; ICD after arrest |
| Short QT syndrome | Arrest at any age; atrial fibrillation | Very short QT | ECG, family history, genetics | ICD after arrest; quinidine as the alternative |
| Early repolarisation syndrome | Often none; ischaemia or temperature change can precipitate | J-point elevation in inferior or lateral leads | ECG plus a history of VF or arrhythmic syncope | ICD after VF; quinidine for repeated shocks |
| Long QT syndrome | Exercise, emotion, noise or sleep | Long QT | ECG, genetics | Beta-blocker; avoid QT-prolonging drugs |
| Brugada syndrome | Rest, sleep or fever | Coved ST elevation in V1–V2 | ECG, sodium-channel blocker challenge | ICD if high risk; treat fever promptly |
Goal of treatment
Prevent sudden death: find out who is at risk, remove triggers, suppress arrhythmias with drugs, protect the highest-risk patients with an ICD and screen relatives.
Treatment
- Medical
- CPVT: a long-acting non-selective beta-blocker without intrinsic sympathomimetic activity (nadolol or slow-release propranolol) for symptomatic patients, considered for asymptomatic carriers; flecainide added if events continue.
- Procedure
- ICD after cardiac arrest or sustained VT/VF in all three syndromes; considered in early repolarisation with arrhythmic syncope plus high-risk features. In CPVT, shocks can trigger electrical storm, so drugs are optimised first.
- Surgical
- Left cardiac sympathetic denervation in CPVT with recurrent events or frequent shocks despite drugs.
- Medical
- Quinidine in short QT when an ICD is declined or not possible or for recurrent VT/VF, and for frequent ICD shocks in early repolarisation syndrome; intravenous isoproterenol in hospital during electrical storm.
- Lifestyle
- CPVT: exercise restriction has been the rule; selected low-risk patients may share the decision about sport, with a defibrillator available.
- Follow-up
- Repeated exercise testing in CPVT; ECG and clinical screening of first-degree relatives, with cascade genetic testing when the family variant is known.
Complications
- Sudden cardiac death, sometimes as the first sign
- Electrical storm, including storms set off by ICD shocks in CPVT
- Inappropriate shocks and device complications in young patients
- Atrial fibrillation (short QT)
- Injury from fainting during exercise
Common traps
- A normal resting ECG rules out an inherited arrhythmia: CPVT has a normal resting ECG and only shows itself on exercise testing
- Every early repolarisation pattern is dangerous: the pattern is common and low risk; it becomes a syndrome only with VF, aborted sudden death or arrhythmic syncope
- A child who faints and jerks during exercise has epilepsy: exertional collapse with jerking can be CPVT and needs an ECG and an exercise test first
- An ICD alone is enough in CPVT: shocks bring pain and adrenaline that can trigger an electrical storm, so beta-blockers (plus flecainide) remain essential
- Short QT is the opposite of long QT, so it is harmless: shortened repolarisation also causes AF, VF and sudden death
Prognosis
Untreated CPVT carries high mortality, about 30 to 50% by age 35 to 40; beta-blockers, flecainide and selected ICDs reduce events. In short QT syndrome about 40% of symptomatic patients have had a cardiac arrest by age 40. An isolated early repolarisation pattern without symptoms or family history carries a very low absolute risk.
Prevention
- Cascade screening of first-degree relatives: ECG, exercise test for CPVT, and genetic testing when a family variant is known
- Cardiac evaluation of anyone who faints during exercise
- Defibrillators available where people with CPVT exercise
Test yourself
Think of the answer, then tap the question to see it.
Which gene is most often affected in CPVT, and what does its protein do?
RYR2, the cardiac ryanodine receptor, which releases calcium from the sarcoplasmic reticulum.
Why is CPVT missed on a resting ECG, and which test reveals it?
The resting ECG is normal because the arrhythmia needs adrenaline; an exercise test provokes ventricular ectopy and bidirectional or polymorphic VT.
What distinguishes the early repolarisation pattern from early repolarisation syndrome?
The pattern is the ECG finding alone; the syndrome adds VF, aborted sudden death or arrhythmic syncope without structural heart disease.
How do the ion-current changes in short QT compare with those in long QT?
They are the opposite: repolarising potassium currents gain function (or inward currents lose it), so the action potential shortens instead of lengthening.
Why must beta-blockers continue in a patient with CPVT who already has an ICD?
Shocks cause pain and adrenaline surges that can trigger more VT and an electrical storm; beta-blockers blunt the trigger.
Why it happens
Connections
Educational information, not medical advice. For any symptom, see a health professional.
Sources: Catecholaminergic Polymorphic Ventricular Tachycardia (MSD Manual Professional Edition, 2026); Catecholaminergic polymorphic ventricular tachycardia (MedlinePlus Genetics, US National Library of Medicine, 2026); Short QT Interval Syndromes (MSD Manual Professional Edition, 2026); Short QT syndrome (MedlinePlus Genetics, US National Library of Medicine, 2026); Early Repolarization Syndrome (MSD Manual Professional Edition, 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.

